Table 3.
Comparison of LCE3C_LCE3B, CSTA, ERAP1 and ZAP70 allele frequencies in the HLA-C*06-positive group in the population of psoriatic patients and controls
| Parameter | HLA-C*06(+) (n) | LCE3C_LCE3B-del (n) | Non-LCE3C_LCE3B-del (n) | P-value* |
|---|---|---|---|---|
| Psoriasis | 97 | 0.603 | 0.397 | 0.770 |
| Control | 32 | 0.578 | 0.422 | |
| HLA-C*06(+) (n) | rs17589 C (n) | rs17589 T (n) | ||
| Psoriasis | 96 | 0.547 | 0.453 | 0.885 |
| Control | 32 | 0.531 | 0.469 | |
| HLA-C*06(+) (n) | rs26653 G (n) | rs26653 C (n) | ||
| Psoriasis | 85 | 0.800 | 0.200 | 0.019855 |
| Control | 23 | 0.630 | 0.370 | |
| HLA-C*06(+) (n) | rs17695937 G (n) | rs17695937 A (n) | ||
| Psoriasis | 97 | 0.242 | 0.758 | 0.301 |
| Control | 32 | 0.172 | 0.828 |
*Fisher’s exact test.